|
|
||||||||||
|
J Am Coll Cardiol, 1998; 32:476-482 © 1998 by the American College of Cardiology Foundation |
a Zena & Michael A. Wiener Cardiovascular Institute, and the Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA
Manuscript received October 6, 1997; revised manuscript received March 13, 1998, accepted April 23, 1998.
Address for correspondence: Dr. John A. Ambrose, Cardiovascular Institute (Box 1030), The Mount Sinai Hospital, One Gustave L. Levy Place, New York, New York 10029
john_ambrose{at}smtplink.mssm.edu
Objective. We sought to determine whether a prolonged QRS interval duration is associated with decreased left ventricular (LV) systolic function.
Background. The 12-lead electrocardiogram (ECG) is a routine test for suspected cardiac disease. Although several scoring systems have been devised to estimate LV systolic function, no studies have examined the direct relationship between QRS duration alone and LV systolic function.
Methods. We analyzed the standard 12-lead surface ECG of 270 consecutive patients, referred for radionuclide ventriculography. Patients (n = 44) with bundle branch blocks, atrial flutter or fibrillation, pacemaker rhythm, recent myocardial infarction or bypass surgery, and patients on antiarrhythmic drugs were excluded. In the remaining patients (n = 226), we correlated the QRS duration on standard resting ECG, and the resting LV ejection fraction (EF), end-systolic and end-diastolic counts (ESC and EDC, respectively; LV volume indices), as obtained by radionuclide angiography. We used a multivariate analysis to identify independent predictors of reduced ventricular function entering QRS duration, the previously described R-wave score and clinical variables in our model.
Results. The QRS duration in the abnormal EF group was significantly longer than in the normal EF group (0.102 vs. 0.091 s, p < 0.0001). A QRS duration >0.10 s was highly specific (83.6%), but modestly sensitive (43.8%), for the prediction of abnormal EF. Furthermore, an abnormal EF was predicted with incrementally increased specificity (83.6% to 99.3%) and a corresponding decrease in sensitivity (43.8% to 13.8%) for each 0.01-s increase in the definition of prolonged QRS (from >0.10 to >0.12 s). Accordingly, the positive likelihood ratio for the prediction of decreased LV function was increased from 2.67 to 19.7 as the definition of prolonged QRS duration was increased from >0.10 to >0.12 s. In the multivariate analysis, a prolonged QRS duration and a low R-wave score were the only independent predictors of decreased LV systolic function.
Conclusions. Prolonged QRS duration (>0.10 s) obtained from a standard resting 12-lead ECG is a specific, but relatively insensitive indicator of decreased LV systolic function. Further prolongation of the QRS had a higher specificity for decreased LV EF and a higher positive likelihood ratio for predicting abnormal LV EF.
| ||||||||||||||
This article has been cited by other articles:
![]() |
Z. Emkanjoo, M. Esmaeilzadeh, N. Mohammad Hadi, A. Alizadeh, M. Tayyebi, and M.A. Sadr-ameli Frequency of inter- and intraventricular dyssynchrony in patients with heart failure according to QRS width Europace, December 1, 2007; 9(12): 1171 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sirker, M. Thomas, S. Baker, J. Shrimpton, S. Jewell, L. Lee, R. Rankin, V. Griffiths, N. Cooter, R. James, et al. Cardiac resynchronization therapy: left or left-and-right for optimal symptomatic effect the LOLA ROSE study Europace, October 1, 2007; 9(10): 862 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J.W. Gotte, T. Germans, I. K. Russel, J. J.M. Zwanenburg, J. T. Marcus, A. C. van Rossum, and D. J. van Veldhuisen Myocardial Strain and Torsion Quantified by Cardiovascular Magnetic Resonance Tissue Tagging: Studies in Normal and Impaired Left Ventricular Function J. Am. Coll. Cardiol., November 21, 2006; 48(10): 2002 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dhingra, M. J. Pencina, T. J. Wang, B.-H. Nam, E. J. Benjamin, D. Levy, M. G. Larson, W. B. Kannel, R. B. D'Agostino Sr, and R. S. Vasan Electrocardiographic QRS Duration and the Risk of Congestive Heart Failure: The Framingham Heart Study Hypertension, May 1, 2006; 47(5): 861 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Helm, L. Younes, M. F. Beg, D. B. Ennis, C. Leclercq, O. P. Faris, E. McVeigh, D. Kass, M. I. Miller, and R. L. Winslow Evidence of Structural Remodeling in the Dyssynchronous Failing Heart Circ. Res., January 6, 2006; 98(1): 125 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kashani and S. S. Barold Significance of QRS Complex Duration in Patients With Heart Failure J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2183 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-Y. Cho, J.-K. Song, W.-J. Park, S.-W. Han, S.-H. Choi, Y.-C. Doo, D.-J. Oh, and Y. Lee Mechanical Dyssynchrony Assessed by Tissue Doppler Imaging Is a Powerful Predictor of Mortality in Congestive Heart Failure With Normal QRS Duration J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2237 - 2243. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Triola, M. B. Olson, S. E. Reis, P. Rautaharju, C. N. B. Merz, S. F. Kelsey, L. J. Shaw, B. L. Sharaf, G. Sopko, and S. Saba Electrocardiographic Predictors of Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study J. Am. Coll. Cardiol., July 5, 2005; 46(1): 51 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bernheim, P. Ammann, C. Sticherling, P. Burger, B. Schaer, H. P. Brunner-La Rocca, J. Eckstein, S. Kiencke, C. Kaiser, A. Linka, et al. Right Atrial Pacing Impairs Cardiac Function During Resynchronization Therapy: Acute Effects of DDD Pacing Compared to VDD Pacing J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1482 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dhingra, B. Ho Nam, E. J. Benjamin, T. J. Wang, M. G. Larson, R. B. D'Agostino Sr, D. Levy, and R. S. Vasan Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: The Framingham Heart Study J. Am. Coll. Cardiol., March 1, 2005; 45(5): 685 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Padeletti, M. Giaccardi, F. Turreni, N. Musilli, A. Colella, P. Pieragnoli, A. Michelucci, G. Ricciardi, and M. C. Porciani Influence of QRS prolongation on the natural history of CHF Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D79 - D82. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bader, S. Garrigue, S. Lafitte, S. Reuter, P. Jais, M. Haissaguerre, J. Bonnet, J. Clementy, and R. Roudaut Intra-left ventricular electromechanical asynchrony: A new independent predictor of severe cardiac events in heart failure patients J. Am. Coll. Cardiol., January 21, 2004; 43(2): 248 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
T H Marwick Techniques for comprehensive two dimensional echocardiographic assessment of left ventricular systolic function Heart, November 1, 2003; 89(90003): iii2 - 8. [Full Text] [PDF] |
||||
![]() |
D. J. Bradley, E. A. Bradley, K. L. Baughman, R. D. Berger, H. Calkins, S. N. Goodman, D. A. Kass, and N. R. Powe Cardiac Resynchronization and Death From Progressive Heart Failure: A Meta-analysis of Randomized Controlled Trials JAMA, February 12, 2003; 289(6): 730 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Shenkman, V. Pampati, A. K. Khandelwal, J. McKinnon, D. Nori, S. Kaatz, K. R. Sandberg, and P. A. McCullough Congestive Heart Failure and QRS Duration* : Establishing Prognosis Study Chest, August 1, 2002; 122(2): 528 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.A Kass Ventricular dyssynchrony and mechanisms of resynchronization therapy Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D23 - D30. [Abstract] [PDF] |
||||
![]() |
C. Leclercq and D. A. Kass Retiming the failing heart: principles and current clinical status of cardiac resynchronization J. Am. Coll. Cardiol., January 16, 2002; 39(2): 194 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Walker, T.M. Levy, A.J.S. Coats, N.S. Peters, and V.E. Paul Bi-ventricular pacing in congestive cardiac failure. Current experience and future directions Eur. Heart J., June 1, 2000; 21(11): 884 - 889. [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |